Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
HealthStream
HSTM
$819M
| $767K | ﹤0.01% |
26,890
-6,563
| -20% | -$192K |
|
2927
Talos Energy
TALO
$2.53B
| $767K | ﹤0.01% |
55,725
+23,160
| +71% | +$282K |
|
|
IIF
2928
Morgan Stanley India Investment Fund
IIF
$217M
| $764K | ﹤0.01% |
24,049
| – | – |
|
|
SILK
2929
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $763K | ﹤0.01% |
13,866
+3,571
| +35% | +$187K |
|
|
TPC
2930
Tutor Perini Cor
TPC
$4.41B
| $762K | ﹤0.01% |
58,726
+52,364
| +823% | +$715K |
|
2931
Iovance Biotherapeutics
IOVA
$1.82B
| $761K | ﹤0.01% |
30,890
-59,373
| -66% | -$1.4M |
|
|
SRDX
2932
DELISTED
Surmodics
SRDX
| $760K | ﹤0.01% |
13,678
+6,160
| +82% | +$342K |
|
|
NTUS
2933
DELISTED
Natus Medical Inc
NTUS
| $760K | ﹤0.01% |
30,285
+7,538
| +33% | +$192K |
|
2934
OraSure Technologies
OSUR
$279M
| $759K | ﹤0.01% |
67,126
+19,926
| +42% | +$219K |
|
2935
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
| $758K | ﹤0.01% |
114,956
-30,907
| -21% | -$200K |
|
2936
Ocular Therapeutix
OCUL
$1.79B
| $757K | ﹤0.01% |
75,737
+59,369
| +363% | +$667K |
|
2937
Gabelli Equity Trust
GAB
$1.75B
| $756K | ﹤0.01% |
121,173
-178,587
| -60% | -$1.21M |
|
2938
Quince Therapeutics
QNCX
$22.9M
| $756K | ﹤0.01% |
41
+27
| +193% | +$429K |
|
2939
iShares International Treasury Bond ETF
IGOV
$1.53B
| $754K | ﹤0.01% |
14,674
+2,422
| +20% | +$128K |
|
2940
Santander
BSBR
$42.5B
| $752K | ﹤0.01% |
119,937
+104,127
| +659% | +$750K |
|
2941
Byline Bancorp
BY
$1.78B
| $752K | ﹤0.01% |
30,620
+9,780
| +47% | +$233K |
|
2942
Adtran
ADTN
$689M
| $750K | ﹤0.01% |
39,991
+13,327
| +50% | +$280K |
|
2943
PUT
T-Mobile US
TMUS
$185B
| $747K | ﹤0.01% |
5,850
| – | – |
|
|
RAD
2944
DELISTED
Rite Aid Corporation
RAD
| $746K | ﹤0.01% |
52,571
+982
| +2% | +$15.5K |
|
2945
DMC Global
BOOM
$138M
| $745K | ﹤0.01% |
20,181
+10,115
| +100% | +$438K |
|
2946
iShares MSCI Singapore ETF
EWS
$1.04B
| $745K | ﹤0.01% |
+32,729
| New | +$760K |
|
|
HFRO
2947
Highland Opportunities and Income Fund
HFRO
$417M
| $745K | ﹤0.01% |
53,624
+8,275
| +18% | +$88.6K |
|
2948
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $745K | ﹤0.01% |
3,157
-1,474
| -32% | -$357K |
|
|
EGIO
2949
DELISTED
Edgio, Inc. Common Stock
EGIO
| $744K | ﹤0.01% |
7,821
+866
| +12% | +$91.3K |
|
2950
Assembly Biosciences
ASMB
$498M
| $742K | ﹤0.01% |
17,748
+4,235
| +31% | +$178K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.